摘要
目的观察口服布洛芬混悬液治疗新生儿动脉导管未闭的临床疗效。方法将96例确诊为PDA的新生儿患者在能进奶时给予口服布洛芬混悬液(美林100mL),第1次给予0.5mL/kg,第2、3次均0.25mL/kg,每次间隔24h,服完第3次后24h做心脏彩色多普勒,若未闭合,继续服第2个疗程。结果 96例PDA的新生儿口服美林后有82例闭合,闭合率达85.42%。结论口服布洛芬混悬液治疗新生儿动脉导管未闭的疗效好,且不良反应小。
Objective To observe the clinical efficacy of oral ibuprofen suspension for the treatment of neonatal patent ductus ar- teriosus. Methods The heart color Doppler diagnosed the PDA 96 newborns were given oral ibuprofen suspension（Merrill Lynch 100mL）, first time were given 0.5mL/kg, second and third time were given 0.25mL/kg, every time interval was 24h, served after third times 24h were made the heart color Doppler, if not closed, continue to take second courses. Results In 96 PDA patients, 82 newborns were closed after oral ibuprofen suspension treatment, closure rate was 85.42%. Conclusion Oral ibuprofen suspension had better effect and had few adverse effect in treating neonatal PDA.
出处
《中外医疗》
2012年第21期8-8,10,共2页
China & Foreign Medical Treatment
关键词
布洛芬混悬液
动脉导管未闭
新生儿
Ibuprofen suspension
Patent ductus arteriosus
Neonatal
